Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    18308010 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed MK0524A Phase IIb Study (0524A-011)(COMPLETED)
Condition: Flushing
Interventions: Drug: Comparator: niacin / Duration of Treatment: 17 Weeks;   Drug: MK0524A, niacin (+) laropiprant / Duration of Treatment: 17 Weeks;   Drug: Comparator: placebo (unspecified) / Duration of Treatment: 17 Weeks

Study has passed its completion date and status has not been verified in more than two years.